A Unique Opportunity to Shape and Inform Measure Development

Participating in the Process: Nomination-Based Panels and Groups

For PQA members who want to be further involved in the measurement development process, PQA’s process includes multiple opportunities for members to participate in panels throughout the development lifecycle. Panel members are selected through a self-nomination process that considers each candidate’s experience and expertise to ensure a balanced and effective group.

Measure Concept Advisory Groups

Composed of approximately 30 members selected through a self-nomination process to advise PQA during measure conceptualization. These groups are convened as needed, in a time-limited fashion and include members with clinical, measurement, and implementation expertise and lived experience that is directly applicable to the concepts being considered.

Measure Update Panel

A standing panel composed of 25-30 members, selected by PQA staff through a self-nomination process, to review PQA measures to ensure they continue to align with current clinical evidence and/or guidelines and that the measures remain viable for use in the marketplace. The panel meets monthly and as needed via webinar, and members can serve a maximum of two two-year terms.

Measure Validity Panel

A standing panel composed of 10-15 members selected by PQA staff to determine whether the performance scores resulting from the measure can be used to distinguish good from poor quality clinical care (i.e., validity). The Measure Validity Panel is composed of a subset of the Measure Update Panel. The panel meets on an ad hoc basis via webinar.

Quality Metrics Expert Panel

A standing panel composed of 20-25 technically proficient members selected by PQA staff through a self-nomination process, to review draft measure specifications and testing plans, review measure testing results, and recommend measures for endorsement and retirement consideration by PQA membership. The panel meets monthly and as needed and QMEP members serve a maximum of two three-year terms.

Risk Adjustment Advisory Panel

A panel composed of 15-20 members, selected by PQA staff through a self-nomination process, to evaluate the need for clinical and/or sociodemographic status risk adjustment for PQA measures in use, and measure concepts under development. The panel is convened via webinar as needed and in a time-limited fashion, and includes individuals with expertise in risk adjustment methodology and healthcare disparity research.

Technical Expert Panels

Small, technically proficient panels composed of 10-15 members, and external experts as needed, who are selected through a self-nomination process to guide the measure specification process and provide expert input during the measure development process. These groups are convened as needed in a time-limited fashion, and include members with clinical, measurement, and implementation expertise that is directly applicable to the measure concepts being developed. Current technical expert panels are listed below. Please note that measure descriptions may be refined over the course of development.

• Hemoglobin A1c / Blood Pressure Reporting (Pharmacy): This TEP is developing measure concepts to assess the percentage of the pharmacy’s diabetes panel with hemoglobin A1c value reported to the health plan, and the percentage of the pharmacy’s hypertension panel with BP reading reported to the health plan.
• Antidepressant Medication Management (Pharmacy): This TEP is developing measure concepts to assess the percentage of individuals at the pharmacy with major depression who were initiated on an antidepressant drug and who completed a period of continuous medication treatment (six months).
• Proportion of Days Covered Composite (Pharmacy): This TEP is developing a measure concept that combines pharmacy performance on adherence to diabetes medications, renin angiotensin system (RAS) antagonists, and statins into a single composite score.